| Title : Parkinson's disease psychosis management: an evidence based, experience informed, pragmatic approach - Friedman_2024_Expert.Opin.Pharmacother__1 |
| Author(s) : Friedman JH |
| Ref : Expert Opin Pharmacother , :1 , 2024 |
| Abstract : INTRODUCTION: Psychotic symptoms in people with Parkinson's disease (PD) have attracted increasing. Recommendations on treating psychosis often fail to take into account what psychotic symptoms require treatment, which has been complicated by the increasing number of reports documenting the frequency of 'minor' hallucinations. AREAS COVERED: This article focuses both on the phenomenology of psychotic symptoms and their management. EXPERT OPINION: Understanding the nature and implications of the types of psychotic symptoms in PD is the key to proper treatment. Evidence and experience-based data on the effect of anti-psychotic medications will be reviewed and how the various clinical settings should determine the treatment approach. The evidence base consists of all reported blinded trials recorded in PubMed and the experience-based studies are those chosen by the author from PubMed as illustrative. Specific recommendations for the treatment of psychosis will be listed for specific situations. Pimavanserin is the first-line choice for mild symptoms; quetiapine for symptoms that require improvement in a short period and clozapine for urgent problems or those which fail the other approaches. |
| ESTHER : Friedman_2024_Expert.Opin.Pharmacother__1 |
| PubMedSearch : Friedman_2024_Expert.Opin.Pharmacother__1 |
| PubMedID: 38344806 |
Friedman JH (2024)
Parkinson's disease psychosis management: an evidence based, experience informed, pragmatic approach
Expert Opin Pharmacother
:1
Friedman JH (2024)
Expert Opin Pharmacother
:1